Organicell announces three new COVID-19 patients treated with Zofin report improvement. Organicell commences Phase I/II clinical trial enrollment.
The six outpatients with different stages of COVID-19 were treated with Zofin under an emergency investigational new drug expanded access program, with physicians for all six patients reporting significant improvement.